Imerys SA, which mines talc used in Johnson & Johnson’s iconic Baby Powder and other products, agreed to turn over its North American operations to resolve more than 14,000 lawsuits claiming the mineral caused cancer in some consumers. Imerys Talc …
Barbara Snowden dreamed of opening a wig shop to help women who’d lost their hair during chemotherapy feel better as they battled cancer. In November, she beamed at the grand opening of Hair Goals Club in the Houston suburb of …
Johnson & Johnson was ordered to pay $344 million for misrepresenting the risks of vaginal-mesh implants to consumers in California, the first state to bring its claim against the company to trial after thousands of U.S. women sued and some …
All Tesla Inc. directors except Chief Executive Officer Elon Musk agreed to a $60 million settlement to resolve shareholder lawsuits over the company’s purchase of SolarCity, according to people familiar with the deal. Insurers covering Tesla’s directors and executives will …
McKesson Corp.’s board reached a $175 million settlement with investors who claimed directors failed to maintain adequate internal systems for spotting suspicious opioid shipments, as the U.S.’s largest drug distributor continues to grapple with claims it helped fuel a public-health …
In an effort to settle tens of thousands of claims that Bayer AG’s Roundup weedkiller causes cancer, lawyers for some plaintiffs are discussing with the company deals that could lead to a total payout of about $10 billion, according to …
A study of more than 250,000 women found that those who used talc or other personal-hygiene powders weren’t significantly more likely to develop ovarian cancer, news that will impact thousands of legal claims against drugmaker Johnson & Johnson over the …
Johnson & Johnson agreed in the middle of a trial to pay more than $2 million to resolve a woman’s claims that asbestos-laced baby powder caused her cancer, according to people familiar with the case. The settlement marks a rare …
DuPont de Nemours Inc. never intended to saddle its spinoff Chemours Co. with “unlimited exposure” to its liabilities, DuPont’s former chief executive officer said, sending Chemours stock up sharply. Ellen Kullman, who resigned as DuPont’s CEO and chairman in 2015 …
Johnson & Johnson agreed to pay $117 million to settle 41 states’ claims that it misrepresented the risks of vaginal-mesh products used to bolster sagging organs and treat incontinence in women. A group of state attorneys general argued after an …
